Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
doi: 10.1155/2013/956792 221 PolonikovA
Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by CHK1 inhibition
Despite the use of fungal CYP51A1 inhibitors in preclinical models, their applicability to human diseases is limited due to structural differences between human and microbial CYP51A1
doi:10.1016/S0021-9258(18)55367-9
Symptoms may include: Skin rashes Itching Difficulty breathing Swelling of the face or throat If any severe allergic reaction occurs, immediate medical attention is necessary
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
